{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:22:54Z","timestamp":1793164974831,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T00:00:00Z","timestamp":1545436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81572899"],"award-info":[{"award-number":["81572899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10072-018-3669-7","type":"journal-article","created":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T12:27:14Z","timestamp":1545481634000},"page":"535-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Imaging features (CT, MRI, MRS, and PET\/CT) of primary central nervous system lymphoma in immunocompetent patients"],"prefix":"10.1007","volume":"40","author":[{"given":"Gang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9261-9382","authenticated-orcid":false,"given":"Jianning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"issue":"1","key":"3669_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncpneuro0395","volume":"3","author":"FH Hochberg","year":"2007","unstructured":"Hochberg FH, Baehring JM, Hochberg EP (2007) Primary CNS lymphoma. Nat Clin Pract Neurol 3(1):24\u201335. \n                              https:\/\/doi.org\/10.1038\/ncpneuro0395","journal-title":"Nat Clin Pract Neurol"},{"issue":"8","key":"3669_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/cncr.22989","volume":"110","author":"IS Haldorsen","year":"2007","unstructured":"Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D, Johannesen TB, Mella O, Espeland A (2007) Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003: time trends in a 15-year national survey. Cancer 110(8):1803\u20131814. \n                              https:\/\/doi.org\/10.1002\/cncr.22989","journal-title":"Cancer"},{"issue":"3","key":"3669_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.nurt.2009.04.013","volume":"6","author":"AP Algazi","year":"2009","unstructured":"Algazi AP, Kadoch C, Rubenstein JL (2009) Biology and treatment of primary central nervous system lymphoma. Neurotherapeutics 6(3):587\u2013597. \n                              https:\/\/doi.org\/10.1016\/j.nurt.2009.04.013","journal-title":"Neurotherapeutics"},{"issue":"1","key":"3669_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3978\/j.issn.2304-3865.2015.02.01","volume":"4","author":"E Fraser","year":"2015","unstructured":"Fraser E, Gruenberg K, Rubenstein JL (2015) New approaches in primary central nervous system lymphoma. Chin Clin Oncol 4(1):11. \n                              https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2015.02.01","journal-title":"Chin Clin Oncol"},{"issue":"5","key":"3669_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3747\/co.v17i5.621","volume":"17","author":"S Latta","year":"2010","unstructured":"Latta S, Myint ZW, Jallad B, Hamdi T, Alhosaini MN, Kumar DV, Kheir F (2010) Primary central nervous system T-cell lymphoma in aids patients: case report and literature review. Curr Oncol 17(5):63\u201366","journal-title":"Curr Oncol"},{"issue":"6","key":"3669_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/CCO.0b013e32834b6adc","volume":"23","author":"A Gonzalez-Aguilar","year":"2011","unstructured":"Gonzalez-Aguilar A, Soto-Hernandez JL (2011) The management of primary central nervous system lymphoma related to AIDS in the HAART era. Curr Opin Oncol 23(6):648\u2013653. \n                              https:\/\/doi.org\/10.1097\/CCO.0b013e32834b6adc","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"3669_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.hoc.2005.05.004","volume":"19","author":"YL Kasamon","year":"2005","unstructured":"Kasamon YL, Ambinder RF (2005) AIDS-related primary central nervous system lymphoma. Hematol Oncol Clin North Am 19(4):665\u2013687, vi-vii. \n                              https:\/\/doi.org\/10.1016\/j.hoc.2005.05.004","journal-title":"Hematol Oncol Clin North Am"},{"issue":"22","key":"3669_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1470-7330-14-22","volume":"14","author":"A Mansour","year":"2014","unstructured":"Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA (2014) MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging 14(22):1\u20139. \n                              https:\/\/doi.org\/10.1186\/1470-7330-14-22","journal-title":"Cancer Imaging"},{"issue":"2","key":"3669_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11060-004-3390-7","volume":"72","author":"W Kuker","year":"2005","unstructured":"Kuker W, Nagele T, Korfel A, Heckl S, Thiel E, Bamberg M, Weller M, Herrlinger U (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neuro-Oncol 72(2):169\u2013177. \n                              https:\/\/doi.org\/10.1007\/s11060-004-3390-7","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"3669_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/02841850802616752","volume":"50","author":"W Liao","year":"2009","unstructured":"Liao W, Liu Y, Wang X, Jiang X, Tang B, Fang J, Chen C, Hu Z (2009) Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 50(2):217\u2013225. \n                              https:\/\/doi.org\/10.1080\/02841850802616752","journal-title":"Acta Radiol"},{"issue":"12","key":"3669_CR11","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1200\/JCO.2003.01.135","volume":"21","author":"AJ Ferreri","year":"2003","unstructured":"Ferreri AJ, Abrey LE, Blay JY, Borisch B, Hochman J, Neuwelt EA, Yahalom J, Zucca E, Cavalli F, Armitage J, Batchelor T (2003) Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Oncol 21(12):2407\u20132414. \n                              https:\/\/doi.org\/10.1200\/JCO.2003.01.135","journal-title":"J Clin Oncol"},{"issue":"4","key":"3669_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1552-6569.2007.00231.x","volume":"18","author":"TT Zacharia","year":"2008","unstructured":"Zacharia TT, Law M, Naidich TP, Leeds NE (2008) Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging 18(4):411\u2013417. \n                              https:\/\/doi.org\/10.1111\/j.1552-6569.2007.00231.x","journal-title":"J Neuroimaging"},{"issue":"8","key":"3669_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.crad.2011.03.006","volume":"66","author":"YZ Tang","year":"2011","unstructured":"Tang YZ, Booth TC, Bhogal P, Malhotra A, Wilhelm T (2011) Imaging of primary central nervous system lymphoma. Clin Radiol 66(8):768\u2013777. \n                              https:\/\/doi.org\/10.1016\/j.crad.2011.03.006","journal-title":"Clin Radiol"},{"issue":"2","key":"3669_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s003300101037","volume":"12","author":"A Coulon","year":"2002","unstructured":"Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J (2002) Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 12(2):329\u2013340. \n                              https:\/\/doi.org\/10.1007\/s003300101037","journal-title":"Eur Radiol"},{"issue":"10","key":"3669_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1001\/archneur.62.10.1595","volume":"62","author":"AM Omuro","year":"2005","unstructured":"Omuro AM, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, Deangelis LM, Abrey LE (2005) Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 62(10):1595\u20131600. \n                              https:\/\/doi.org\/10.1001\/archneur.62.10.1595","journal-title":"Arch Neurol"},{"issue":"18","key":"3669_CR16","doi-asserted-by":"publisher","first-page":"25783","DOI":"10.18632\/oncotarget.8370","volume":"7","author":"L Qian","year":"2016","unstructured":"Qian L, Zhou C, Shen J, Cen J, Yin W (2016) Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy. Oncotarget 7(18):25783\u201325790. \n                              https:\/\/doi.org\/10.18632\/oncotarget.8370","journal-title":"Oncotarget"},{"issue":"4","key":"3669_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3174\/ajnr.A1447","volume":"30","author":"IS Haldorsen","year":"2009","unstructured":"Haldorsen IS, Krakenes J, Krossnes BK, Mella O, Espeland A (2009) CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol 30(4):744\u2013751. \n                              https:\/\/doi.org\/10.3174\/ajnr.A1447","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"3669_CR18","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1007\/s00330-010-1817-4","volume":"20","author":"P Schramm","year":"2010","unstructured":"Schramm P, Xyda A, Klotz E, Tronnier V, Knauth M, Hartmann M (2010) Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas. Eur Radiol 20(10):2482\u20132490. \n                              https:\/\/doi.org\/10.1007\/s00330-010-1817-4","journal-title":"Eur Radiol"},{"issue":"6","key":"3669_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3174\/ajnr.A2171","volume":"32","author":"IS Haldorsen","year":"2011","unstructured":"Haldorsen IS, Espeland A, Larsson EM (2011) Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 32(6):984\u2013992. \n                              https:\/\/doi.org\/10.3174\/ajnr.A2171","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"3669_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3348\/kjr.2010.11.3.269","volume":"11","author":"D Zhang","year":"2010","unstructured":"Zhang D, Hu LB, Henning TD, Ravarani EM, Zou LG, Feng XY, Wang WX, Wen L (2010) MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol 11(3):269\u2013277. \n                              https:\/\/doi.org\/10.3348\/kjr.2010.11.3.269","journal-title":"Korean J Radiol"},{"issue":"5","key":"3669_CR21","doi-asserted-by":"publisher","DOI":"10.3171\/foc.2006.21.5.16","volume":"21","author":"AF Eichler","year":"2006","unstructured":"Eichler AF, Batchelor TT (2006) Primary central nervous system lymphoma: presentation, diagnosis and staging. Neurosurg Focus 21(5):E15","journal-title":"Neurosurg Focus"},{"issue":"17","key":"3669_CR22","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1158\/0008-5472.CAN-13-3534","volume":"74","author":"NS White","year":"2014","unstructured":"White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjornerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale AM (2014) Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res 74(17):4638\u20134652. \n                              https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3534","journal-title":"Cancer Res"},{"issue":"1","key":"3669_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3174\/ajnr.A1750","volume":"31","author":"RF Barajas Jr","year":"2010","unstructured":"Barajas RF Jr, Rubenstein JL, Chang JS, Hwang J, Cha S (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 31(1):60\u201366. \n                              https:\/\/doi.org\/10.3174\/ajnr.A1750","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"3669_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1148\/radiol.2241010637","volume":"224","author":"AC Guo","year":"2002","unstructured":"Guo AC, Cummings TJ, Dash RC, Provenzale JM (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224(1):177\u2013183. \n                              https:\/\/doi.org\/10.1148\/radiol.2241010637","journal-title":"Radiology"},{"issue":"5","key":"3669_CR25","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2214\/AJR.09.2486","volume":"193","author":"M Horger","year":"2009","unstructured":"Horger M, Fenchel M, Nagele T, Moehle R, Claussen CD, Beschorner R, Ernemann U (2009) Water diffusivity: comparison of primary CNS lymphoma and astrocytic tumor infiltrating the corpus callosum. AJR Am J Roentgenol 193(5):1384\u20131387. \n                              https:\/\/doi.org\/10.2214\/AJR.09.2486","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"3669_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.crad.2008.07.002","volume":"64","author":"DP Soares","year":"2009","unstructured":"Soares DP, Law M (2009) Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 64(1):12\u201321. \n                              https:\/\/doi.org\/10.1016\/j.crad.2008.07.002","journal-title":"Clin Radiol"},{"key":"3669_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbacli.2016.04.002","volume":"5","author":"A Verma","year":"2016","unstructured":"Verma A, Kumar I, Verma N, Aggarwal P, Ojha R (2016) Magnetic resonance spectroscopy - revisiting the biochemical and molecular milieu of brain tumors. BBA Clin 5:170\u2013178. \n                              https:\/\/doi.org\/10.1016\/j.bbacli.2016.04.002","journal-title":"BBA Clin"},{"issue":"3","key":"3669_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0304-3940(03)00272-6","volume":"342","author":"I Harting","year":"2003","unstructured":"Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342(3):163\u2013166","journal-title":"Neurosci Lett"},{"issue":"2","key":"3669_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-004-1360-8","volume":"71","author":"JJ Raizer","year":"2005","unstructured":"Raizer JJ, Koutcher JA, Abrey LE, Panageas KS, DeAngelis LM, Lis E, Xu S, Zakian KL (2005) Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. J Neuro-Oncol 71(2):173\u2013180. \n                              https:\/\/doi.org\/10.1007\/s11060-004-1360-8","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"3669_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1148\/radiology.194.1.7997566","volume":"194","author":"A Bizzi","year":"1995","unstructured":"Bizzi A, Movsas B, Tedeschi G, Phillips CL, Okunieff P, Alger JR, Di Chiro G (1995) Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging. Radiology 194(1):271\u2013276. \n                              https:\/\/doi.org\/10.1148\/radiology.194.1.7997566","journal-title":"Radiology"},{"issue":"11","key":"3669_CR31","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/MNM.0b013e328264ae7f","volume":"28","author":"D Karantanis","year":"2007","unstructured":"Karantanis D, O'Eill BP, Subramaniam RM, Witte RJ, Mullan BP, Nathan MA, Lowe VJ, Peller PJ, Wiseman GA (2007) 18F-FDG PET\/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun 28(11):834\u2013841. \n                              https:\/\/doi.org\/10.1097\/MNM.0b013e328264ae7f","journal-title":"Nucl Med Commun"},{"issue":"25","key":"3669_CR32","doi-asserted-by":"publisher","first-page":"41518","DOI":"10.18632\/oncotarget.17456","volume":"8","author":"Y Zou","year":"2017","unstructured":"Zou Y, Tong J, Leng H, Jiang J, Pan M, Chen Z (2017) Diagnostic value of using 18F-FDG PET and PET\/CT in immunocompetent patients with primary central nervous system lymphoma: a systematic review and meta-analysis. Oncotarget 8(25):41518\u201341528. \n                              https:\/\/doi.org\/10.18632\/oncotarget.17456","journal-title":"Oncotarget"},{"issue":"2","key":"3669_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00259-005-1917-6","volume":"33","author":"H Palmedo","year":"2006","unstructured":"Palmedo H, Urbach H, Bender H, Schlegel U, Schmidt-Wolf IG, Matthies A, Linnebank M, Joe A, Bucerius J, Biersack HJ, Pels H (2006) FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up. Eur J Nucl Med Mol Imaging 33(2):164\u2013168. \n                              https:\/\/doi.org\/10.1007\/s00259-005-1917-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"3669_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cpet.2013.10.006","volume":"9","author":"V Berti","year":"2014","unstructured":"Berti V, Mosconi L, Pupi A (2014) Brain: normal variations and benign findings in fluorodeoxyglucose-PET\/computed tomography imaging. PET Clin 9(2):129\u2013140. \n                              https:\/\/doi.org\/10.1016\/j.cpet.2013.10.006","journal-title":"PET Clin"},{"issue":"5","key":"3669_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12149-010-0356-z","volume":"24","author":"N Kawai","year":"2010","unstructured":"Kawai N, Okubo S, Miyake K, Maeda Y, Yamamoto Y, Nishiyama Y, Tamiya T (2010) Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings. Ann Nucl Med 24(5):335\u2013343. \n                              https:\/\/doi.org\/10.1007\/s12149-010-0356-z","journal-title":"Ann Nucl Med"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-018-3669-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-018-3669-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-018-3669-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T19:06:44Z","timestamp":1576955204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-018-3669-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,22]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3669"],"URL":"https:\/\/doi.org\/10.1007\/s10072-018-3669-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,22]]},"assertion":[{"value":"28 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"<b>Disclosure of potential conflicts of interest<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethic Committee of the hospital. This article does not contain any studies with animals performed by any of the authors","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The need for individual consent was waived by the committee because of the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}